| Q4 & FY2026 Earnings Conference Call
Summary : Star Health achieved significant underwriting profit turnaround and strong retail growth in FY26, driven by strategic recalibration and improved loss ratios, despite market volatility.
Management Perspective positive : "FY26 was a year of strategic recalibration for us, focused towards strengthening our performance.""The green shoots of our operating turnaround in the previous quarters is now more pronounced.""India's health insurance has entered what we describe as a structurally advanced growth phase.""We are well placed to see a continuous improvement in our loss ratios going forward.""We remain confident that disciplined execution at scale will translate into sustainable, risk-first balance of growth and ROE."
Concall Report Analysis & Insights
Business Overview
- FY26 focused on distribution, underwriting, claims, customer experience, and efficiency.
- Maintained leadership in Retail Health insurance with 31.3% market share.
- GWP increased 16% YoY to Rs. 20,369 crore, crossing a key milestone.
- Underwriting profit turned positive at Rs. 206 crore for FY26.
- Normalized PAT grew 45% YoY to Rs. 1,222 crore, ROE expanded to 13.1%.
Future Growth Prospects
- India's health insurance is in a structurally advanced growth phase.
- Retail Health premiums grew 30.2% YoY in H2 FY26, outpacing non-life.
- Company aims for sustainable high-teen growth and mid-to-high-teen ROE.
- Plans to add 1 lakh agents annually, targeting 1 million in two years.
- Focus on profitable SME segment, contributing 78% of business.
Management Insights
- FY26 was a strategic recalibration year, strengthening core operating levers.
- Focus on quality of growth, emphasizing new-to-insurance customer mix.
- Continuous efforts to manage claims severity through hospital discussions.
- Technology investments improve productivity, service, and customer engagement.
- Strategic growth centers on granular retail franchise and operating scale.
Signs of Skepticism
- Retail loss ratios (68%) still above 2023-2024 levels (65-66%).
- Company's growth is lower than the industry's strong retail growth.
- NEP growth lags GWP growth, needing to catch up to 15% range.
- Retail growth in Q4 (19%) lower than industry growth (29%).
Risk Factors
- Geopolitical tensions caused Rs. 558 crore marked-to-market loss in Q4.
- Business cycles can lead to fluctuations in claims frequency or severity.
- External environment impacts on loss ratios and profitability are possible.
- Regulatory changes like EoM limits could affect non-compliant companies.
Good To Know
- New-to-insurance customers were 94% of H2 FY26 fresh additions.
- Retail claim settlement ratio increased 3% to 92% for full year.
- Renewal ratio on full-year basis increased 2% to 99%.
- Company-level NPS improved 8 points to 62 by March 2026.
- Mobile app has over 14 million downloads, 1.5 million monthly active users.
Key Drivers
- Strong retail growth, 38% YoY.
- Underwriting profit turned positive in FY26.
- Combined ratio improved to 95.7%.
- Normalized PAT grew 45% YoY.
Key Analyst Discussions
Competitive Environment
- Asked why company growth lags industry despite strong retail growth.
- Inquired about strategies for ring-fencing agents amidst competition.
- Questioned Bima Sugam platform's impact on sourcing and renewals.
- Asked about the gap between company's retail growth and industry.
Market Trends & Consumer Behavior
- Asked about mitigating seasonal claims from vector-borne diseases.
- Inquired about policyholder usage of Telemedicine services.
- Questioned price hike management given GST exemption and scrutiny.
- Asked about customer retention and higher sum assured post GST.
Financial Highlights
- Asked about pathway for retail loss ratio improvement to 65-66%.
- Inquired about fresh growth's impact on loss ratio improvement.
- Questioned drivers of commission ratio improvement beyond senior citizens.
- Requested quantum of deferred revenue on long-term policies.
Product Composition
- Asked about price hike status, products affected, and average hike.
- Inquired about fresh business proportion in overall GWP.
- Questioned share of new and renewal business on NEP basis.
- Asked about strategy for the Group Health segment going forward.
Strategic Considerations
- Asked about claims value trajectory, inflation versus frequency.
- Inquired about back book and vintage products' performance trends.
- Questioned regulatory view on EoM for non-compliant companies.
- Asked about Medi Assist platform transition and associated savings.